UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth

Cancer research (Chicago, Ill.), 2009-03, Vol.69 (6), p.2305-2313

2009

Volltextzugriff (PDF)

Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer

Nature communications, 2018-11, Vol.9 (1), p.4700-16, Article 4700

2018

Volltextzugriff (PDF)

Immune modulation resulting from MR-guided high intensity focused ultrasound in a model of murine breast cancer

Scientific reports, 2021-01, Vol.11 (1), p.927-927, Article 927

2021

Volltextzugriff (PDF)

KDM8/JMJD5 as a dual coactivator of AR and PKM2 integrates AR/EZH2 network and tumor metabolism in CRPC

Oncogene, 2019-01, Vol.38 (1), p.17-32

2019

Volltextzugriff (PDF)

Recombinant Origin of the Retrovirus XMRV

Science (American Association for the Advancement of Science), 2011-07, Vol.333 (6038), p.97-101

2011

Volltextzugriff (PDF)

An Androgen-Regulated miRNA Suppresses Bak1 Expression and Induces Androgen-Independent Growth of Prostate Cancer Cells

Proceedings of the National Academy of Sciences - PNAS, 2007-12, Vol.104 (50), p.19983-19988

2007

Volltextzugriff (PDF)

KDM8, a H3K36me2 histone demethylase that acts in the cyclin A1 coding region to regulate cancer cell proliferation

Proceedings of the National Academy of Sciences - PNAS, 2010-05, Vol.107 (21), p.9671-9676

2010

Volltextzugriff (PDF)

The Phosphatidylinositol 3-Kinase Pathway as a Potential Therapeutic Target in Bladder Cancer

Clinical cancer research, 2017-11, Vol.23 (21), p.6580-6591

2017

Volltextzugriff (PDF)

Androgen-Induced Coactivator ANCCA Mediates Specific Androgen Receptor Signaling in Prostate Cancer

Cancer research (Chicago, Ill.), 2009-04, Vol.69 (8), p.3339-3346

2009

Volltextzugriff (PDF)

Obatoclax, a BH3 Mimetic, Enhances Cisplatin-Induced Apoptosis and Decreases the Clonogenicity of Muscle Invasive Bladder Cancer Cells via Mechanisms That Involve the Inhibition of Pro-Survival Molecules as Well as Cell Cycle Regulators

International journal of molecular sciences, 2019-03, Vol.20 (6), p.1285

2019

Volltextzugriff (PDF)

A Syngeneic ErbB2 Mammary Cancer Model for Preclinical Immunotherapy Trials

Journal of mammary gland biology and neoplasia, 2019-06, Vol.24 (2), p.149-162

2019

Volltextzugriff (PDF)

Use of RNA-Seq and a Transgenic Mouse Model to Identify Genes Which May Contribute to Mutant p53-Driven Prostate Cancer Initiation

Biology (Basel, Switzerland), 2022-01, Vol.11 (2), p.218

2022

Volltextzugriff (PDF)

Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence

Cancer research (Chicago, Ill.), 2007-10, Vol.67 (19), p.9001-9005

2007

Volltextzugriff (PDF)

Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis

Acta neuropathologica communications, 2019-04, Vol.7 (1), p.55-55, Article 55

2019

Volltextzugriff (PDF)

KSHV transactivator-derived small peptide traps coactivators to attenuate MYC and inhibits leukemia and lymphoma cell growth

Communications biology, 2021-12, Vol.4 (1), p.1330-1330, Article 1330

2021

Volltextzugriff (PDF)

Abnormal Mammary Development in 129:STAT1-Null Mice is Stroma-Dependent

PloS one, 2015-06, Vol.10 (6), p.e0129895-e0129895

2015

Volltextzugriff (PDF)

microRNAs and prostate cancer

Journal of cellular and molecular medicine, 2008-09, Vol.12 (5a), p.1456-1465

2008

Volltextzugriff (PDF)

MicroRNAs and their potential for translation in prostate cancer

Urologic oncology, 2009-05, Vol.27 (3), p.307-311

2009

Volltextzugriff (PDF)

Inappropriate activation of the androgen receptor by nonsteroids : Involvement of the src kinase pathway and its therapeutic implications

Cancer research (Chicago, Ill.), 2006-11, Vol.66 (21), p.10449-10459

2006

Volltextzugriff (PDF)

Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes

Cancer letters, 2016-08, Vol.378 (2), p.69-79

2016

Volltextzugriff (PDF)

ANCCA/ATAD2 Overexpression Identifies Breast Cancer Patients with Poor Prognosis, Acting to Drive Proliferation and Survival of Triple-Negative Cells through Control of B-Myb and EZH2

Cancer research (Chicago, Ill.), 2010-11, Vol.70 (22), p.9402-9412

2010

Volltextzugriff (PDF)

Multiomic analysis for optimization of combined focal and immunotherapy protocols in murine pancreatic cancer

Theranostics, 2022-01, Vol.12 (18), p.7884-7902

2022

Volltextzugriff (PDF)

The oncogenic potential of a prostate cancer-derived androgen receptor mutant

The Prostate, 2007-05, Vol.67 (6), p.591-602

2007

Volltextzugriff (PDF)

Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line

Cancer research (Chicago, Ill.), 2002-11, Vol.62 (22), p.6606-6614

2002

Volltextzugriff (PDF)

Nrdp1-Mediated Regulation of ErbB3 Expression by the Androgen Receptor in Androgen-Dependent but not Castrate-Resistant Prostate Cancer Cells

Cancer research (Chicago, Ill.), 2010-07, Vol.70 (14), p.5994-6003

2010

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

ThemaTumors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth

Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer

Immune modulation resulting from MR-guided high intensity focused ultrasound in a model of murine breast cancer

KDM8/JMJD5 as a dual coactivator of AR and PKM2 integrates AR/EZH2 network and tumor metabolism in CRPC

Recombinant Origin of the Retrovirus XMRV

An Androgen-Regulated miRNA Suppresses Bak1 Expression and Induces Androgen-Independent Growth of Prostate Cancer Cells

KDM8, a H3K36me2 histone demethylase that acts in the cyclin A1 coding region to regulate cancer cell proliferation

The Phosphatidylinositol 3-Kinase Pathway as a Potential Therapeutic Target in Bladder Cancer

Androgen-Induced Coactivator ANCCA Mediates Specific Androgen Receptor Signaling in Prostate Cancer

Obatoclax, a BH3 Mimetic, Enhances Cisplatin-Induced Apoptosis and Decreases the Clonogenicity of Muscle Invasive Bladder Cancer Cells via Mechanisms That Involve the Inhibition of Pro-Survival Molecules as Well as Cell Cycle Regulators

A Syngeneic ErbB2 Mammary Cancer Model for Preclinical Immunotherapy Trials

Use of RNA-Seq and a Transgenic Mouse Model to Identify Genes Which May Contribute to Mutant p53-Driven Prostate Cancer Initiation

Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence

Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis

KSHV transactivator-derived small peptide traps coactivators to attenuate MYC and inhibits leukemia and lymphoma cell growth

Abnormal Mammary Development in 129:STAT1-Null Mice is Stroma-Dependent

microRNAs and prostate cancer

MicroRNAs and their potential for translation in prostate cancer

Inappropriate activation of the androgen receptor by nonsteroids : Involvement of the src kinase pathway and its therapeutic implications

Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes

ANCCA/ATAD2 Overexpression Identifies Breast Cancer Patients with Poor Prognosis, Acting to Drive Proliferation and Survival of Triple-Negative Cells through Control of B-Myb and EZH2

Multiomic analysis for optimization of combined focal and immunotherapy protocols in murine pancreatic cancer

The oncogenic potential of a prostate cancer-derived androgen receptor mutant

Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line

Nrdp1-Mediated Regulation of ErbB3 Expression by the Androgen Receptor in Androgen-Dependent but not Castrate-Resistant Prostate Cancer Cells

Aktive Filter

Suchergebnisse filtern